Volume 60, Issue 1, Pages (July 2001)

Slides:



Advertisements
Similar presentations
Volume 63, Issue 3, Pages (March 2003)
Advertisements

Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway  William A. Wilmer, Cynthia L. Dixon, Courtney Hebert 
Volume 67, Issue 3, Pages (March 2005)
Harald D. Rupprecht, M.D, Yoshitaka Akagi, Annette Keil, Gerhard Hofer 
Volume 59, Issue 4, Pages (April 2001)
Volume 63, Issue 3, Pages (March 2003)
Volume 68, Issue 5, Pages (November 2005)
Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells  Hi Bahl.
Volume 60, Issue 2, Pages (August 2001)
Progesterone and progestational compounds attenuate tumor necrosis factor alpha– induced interleukin-8 production via nuclear factor kappaB inactivation.
Inhibition of cyclooxygenase 2 expression by diallyl sulfide on joint inflammation induced by urate crystal and IL-1β  H.-S. Lee, M.D., Ph.D., C.-H. Lee,
Volume 71, Issue 6, Pages (March 2007)
Volume 69, Issue 4, Pages (February 2006)
Requirement of heat shock protein 90 in mesangial cell mitogenesis
Volume 60, Issue 3, Pages (September 2001)
Volume 62, Issue 2, Pages (August 2002)
Volume 54, Issue 1, Pages (July 1998)
Genistein protects the kidney from cisplatin-induced injury
Transcriptional activation of transforming growth factor-β1 in mesangial cell culture by high glucose concentration  Brenda B. Hoffman, Kumar Sharma,
Volume 116, Issue 6, Pages (June 1999)
Volume 68, Issue 3, Pages (September 2005)
Volume 68, Issue 1, Pages (July 2005)
Expression and regulation of Toll-like receptor 2 by IL-1β and fibronectin fragments in human articular chondrocytes  S.-L. Su, M.S., C.-D. Tsai, Ph.D.,
Volume 61, Issue 3, Pages (March 2002)
Volume 59, Issue 5, Pages (May 2001)
Evidence for low-density lipoprotein–induced expression of connective tissue growth factor in mesangial cells  Mimi Sohn, Yan Tan, Richard L. Klein, Ayad.
Volume 62, Issue 6, Pages (December 2002)
Volume 63, Issue 2, Pages (February 2003)
Volume 67, Issue 3, Pages (March 2005)
Volume 57, Issue 6, Pages (June 2000)
Volume 57, Issue 4, Pages (April 2000)
Volume 62, Issue 3, Pages (September 2002)
Harald D. Rupprecht, M.D, Yoshitaka Akagi, Annette Keil, Gerhard Hofer 
Volume 60, Issue 3, Pages (September 2001)
Volume 57, Issue 5, Pages (May 2000)
Regulation of renal proximal tubular epithelial cell hyaluronan generation: Implications for diabetic nephropathy  Stuart Jones, Suzanne Jones, Aled Owain.
The Rho-kinase pathway regulates angiotensin II-induced renal damage
Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway  William A. Wilmer, Cynthia L. Dixon, Courtney Hebert 
Estradiol suppresses type I collagen synthesis in mesangial cells via activation of activator protein-1  Sharon Silbiger, Jun Lei, Joel Neugarten  Kidney.
Jin H. Li, Xiao R. Huang, Hong-Jian Zhu, Richard Johnson, Hui Y. Lan 
P. Harding, L. Balasubramanian, J. Swegan, A. Stevens, W.F. Glass 
Volume 70, Issue 4, Pages (August 2006)
Volume 62, Issue 3, Pages (September 2002)
Izabella Z.A. Pawluczyk, Kevin P.G. Harris  Kidney International 
DNA binding of activator protein-1 is increased in human mesangial cells cultured in high glucose concentrations  William A. Wilmer, Fernando G. Cosio 
Volume 84, Issue 6, Pages (December 2013)
Volume 61, Issue 5, Pages (May 2002)
Romain Debret, Richard R
Volume 61, Issue 6, Pages (June 2002)
STAT proteins mediate angiotensin II–induced production of TIMP-1 in human proximal tubular epithelial cells  Xiangmei Chen, Jianzhong Wang, Feng Zhou,
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Volume 56, Pages S178-S181 (July 1999)
Volume 58, Issue 2, Pages (August 2000)
Volume 53, Issue 6, Pages (June 1998)
Volume 55, Issue 6, Pages (June 1999)
High glucose–induced PKC activation mediates TGF-β1 and fibronectin synthesis by peritoneal mesothelial cells  Hunjoo Ha, Mi Ra Yu, Hi Bahl Lee  Kidney.
Volume 60, Issue 3, Pages (September 2001)
Ken Inoki, Masakazu Haneda, Shiro Maeda, Daisuke Koya, Ryuichi Kikkawa 
Curcumin Selectively Induces Apoptosis in Cutaneous T-Cell Lymphoma Cell Lines and Patients’ PBMCs: Potential Role for STAT-3 and NF-κB Signaling  Chunlei.
Lipoxin A4 inhibits connective tissue growth factor-induced production of chemokines in rat mesangial cells  S.-H. Wu, X.-H. Wu, C. Lu, L. Dong, G.-P.
Angiotensin III increases MCP-1 and activates NF-кB and AP-1 in cultured mesangial and mononuclear cells  Marta Ruiz-Ortega, Oscar Lorenzo, Jesus Egido 
Myeloid Differentiation Factor 88 Regulates Basal and UV-Induced Expressions of IL-6 and MMP-1 in Human Epidermal Keratinocytes  Youngae Lee, Hyunjung.
Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis  Jong Hoon Oh, Hunjoo Ha, Mi Ra Yu, Hi Bahl.
Induction of monocyte chemotactic protein-1 in peritoneal mesothelial and endometrial cells by oxidized low-density lipoprotein and peritoneal fluid from.
Volume 62, Issue 2, Pages (August 2002)
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Volume 72, Issue 2, Pages (July 2007)
Bismarck Amoah-Apraku, Mao-Zhong Fang, Nicolas J. Guzman, M.D 
Deon G. Uffort, Elizabeth A. Grimm, Julie A. Ellerhorst 
Volume 56, Issue 3, Pages (September 1999)
Presentation transcript:

Volume 60, Issue 1, Pages 55-64 (July 2001) High glucose induces MCP-1 expression partly via tyrosine kinase–AP-1 pathway in peritoneal mesothelial cells  Sang Koo Lee, M.D., Byung Sik Kim, Weon Suk Yang, Soon Bae Kim, Su Kil Park, Jung Sik Park  Kidney International  Volume 60, Issue 1, Pages 55-64 (July 2001) DOI: 10.1046/j.1523-1755.2001.00770.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Induction of monocyte chemoattractant protein-1 (MCP-1) mRNA by glucose. (A) Time-dependent induction of MCP-1 mRNA by glucose. Human peritoneal mesangial cells (HPMCs) were exposed to 5mmol/L glucose [control (C)] and 100mmol/L glucose (G) for up to seven days. Northern blot analysis was performed. Results shown are representative of three experiments. (B) Dose-dependent induction of MCP-1 mRNA by glucose: HPMCs were exposed to varying concentration of glucose for five days. Kidney International 2001 60, 55-64DOI: (10.1046/j.1523-1755.2001.00770.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Quantitation of MCP-1 mRNA expression in mesothelial cells cultured for six days with glucose or mannitol. HPMCs were exposed to 5mmol/L glucose (control), 50 mmol/L, 100mmol/L glucose, 50mmol/L mannitol, or 100mmol/L mannitol for six days. Northern blot analysis was performed (A), and the MCP-1 mRNA level was normalized by the GAPDH mRNA level (B). Data were mean ± SE of three experiments. aP < 0.05 vs. control. Kidney International 2001 60, 55-64DOI: (10.1046/j.1523-1755.2001.00770.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Effect of glucose and mannitol on the cell supernatant MCP-1 protein. HPMCs were exposed to 5mmol/L glucose (control), 50mmol/L glucose, 100mmol/L glucose, and 100mmol/L mannitol for six days. MCP-1 protein in cell culture supernatant was measured by ELISA. aP < 0.05 vs. control. Kidney International 2001 60, 55-64DOI: (10.1046/j.1523-1755.2001.00770.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 4 Effect of high glucose on the chemotactic activity for monocytes and inhibition by anti–MCP-1 antibody. HPMCs were exposed to 5mmol/L glucose (control) and 100mmol/L glucose for six days. Chemotactic activity in cell-free supernatants before and after the addition of anti–MCP-1 antibody (20 μg/mL) or nonspecific antibody (20 μg/mL) was measured by chemotactic assay. Data are expressed as a percentage of maximum monocyte chemotactic response to f-Met-Leu-Phe (FMLP) 10-8 mol/L. Results were expressed as mean ± SE of six experiments. aP < 0.05 vs. control; bP < 0.05 vs. before the addition of anti–MCP-1 antibody. Kidney International 2001 60, 55-64DOI: (10.1046/j.1523-1755.2001.00770.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 5 Effect of high glucose on activator protein-1 (AP-1) binding activity. (A) Time-dependent increase in AP-1 binding activity by high glucose. Electrophoretic mobility shift assays (EMSA) were performed with nuclear proteins from HPMCs cultured for up to five days in 5mmol/L glucose (C) and 100mmol/L glucose (G). Results shown are representative of three experiments. (B) Dose-dependent increase in AP-1 binding activity by glucose. EMSAs were performed from mesothelial cells cultured with varying doses of glucose for three days. (C) Competition assay of AP-1 binding activity. Competition assay was performed to demonstrate the specificity of AP-1 binding activity. Nuclear protein from HPMCs cultured for three days in 100mmol/L glucose (Control) was preincubated with 100 times excess unlabeled AP-1 oligonucleotide (Competition) and nonspecific oligonucleotide (NS competition) for 10 minutes, and then EMSA was performed. Kidney International 2001 60, 55-64DOI: (10.1046/j.1523-1755.2001.00770.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 6 Effect of high glucose on nuclear factor-κB (NF-κB) binding activity. (A) EMSAs were performed with nuclear proteins from HPMCs cultured for up to five days in 5mmol/L glucose (C) and 100mmol/L glucose (G). Results shown are representative of three experiments. (B) Competition assay was performed to demonstrate the specificity of NF-κB binding activity. Nuclear protein from HPMCs cultured for three days in 100mmol/L glucose (Control) was preincubated with 100 times excess unlabeled NF-κB oligonucleotide (Competition) and nonspecific oligonucleotide (NS competition) for 10 minutes, and then EMSA was performed. Kidney International 2001 60, 55-64DOI: (10.1046/j.1523-1755.2001.00770.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 7 Effect of AP-1 inhibitor, curcumin, on induction of MCP-1 mRNA by high glucose. HPMCs grown in normal (5 mmol/L) and high glucose (100 mmol/L) for three days were treated with curcumin for 24 hours, and then Northern blot analysis was performed. Kidney International 2001 60, 55-64DOI: (10.1046/j.1523-1755.2001.00770.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 8 Effect of tyrosine kinase inhibitors on high-glucose–induced MCP-1 mRNA expression and high-glucose–induced AP-1 binding activity. (A) HPMCs were exposed to 100mmol/L glucose for three days with or without varying dose of genistein and herbimycin A. Northern blot analysis was performed. Results shown are representative of two experiments. (B) Suppression of high-glucose–induced AP-1 binding activity by genistein, herbimycin A and curcumin. EMSAs were performed with nuclear proteins from mesothelial cells cultured for three days in 100mmol/L glucose with or without 50 μmol/L genistein (Ge), 1 μmol/L herbimycin A (He), and 15 μmol/L curcumin (Cu). Results shown are representative of three experiments. Kidney International 2001 60, 55-64DOI: (10.1046/j.1523-1755.2001.00770.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 9 Effect of tyrosine kinase inhibitors and curcumin on the NF-κB binding activity. (A) Effect of genistein (Ge), herbimycin A (He), and curcumin (Cu) on the NF-κB binding activity in mesothelial cells incubated with 100mmol/L glucose. EMSAs were performed with nuclear proteins from mesothelial cells cultured for three days in 100mmol/L glucose with or without 50 μmol/L genistein (Ge), 1 μmol/L herbimycin A (He), and 15 μmol/L curcumin (Cu). Results shown are representative of three experiments. (B) EMSAs were performed with nuclear proteins from mesothelial cells cultured for three days in 5mmol/L glucose (control) with or without 15 μmol/L curcumin (Cu). Kidney International 2001 60, 55-64DOI: (10.1046/j.1523-1755.2001.00770.x) Copyright © 2001 International Society of Nephrology Terms and Conditions